Conferences

UCAN CURE highlighted in Arthritis Society Canada’s Top 10 Research Advances of 2025

Arthritis Society Canada announced its Top 10 Research Advances of 2025 today, highlighting discoveries that are advancing how arthritis is diagnosed, treated and prevented. Among them, the work of the UCAN CURE consortium was highlighted.

Earlier treatment, better outcomes for children with arthritis

For children with non-systemic juvenile idiopathic arthritis (JIA), starting biologic medication earlier can significantly improve treatment success, according to research led by Dr. Susanne Benseler at the University of Calgary, and Dr. Rae Yeung from The Hospital for Sick Children, as part of the UCAN CAN-DU and UCAN CURE consortia.

The study found that 83% of children who began biologics within 6 months of their initial symptoms achieved inactive disease, compared to 57% of those who waited 13 to 24 months. With each month of delay, the odds of still having active arthritis increased by a relative 9%.

These findings reveal a critical window of opportunity for early intervention and could help doctors make more informed decisions about when to initiate biologic therapy, improving the long-term outcomes for children with arthritis. This study marks a critical step towards a cure for childhood arthritis.

Read the full article here.

bpereira2026-02-02T20:13:06+00:00

Dr. Marvin Fritzler honoured in Calgary’s Top 7 over 70 awards

UCAN CURE’s Dr. Marvin Fritzler was recognized for his work in Calgary’s Top 7 over 70 awards!

You can find the article here.

bpereira2025-09-19T17:51:00+00:00

Thank You for Making Childhood Arthritis and Beyond 2024 a Success!

Thank you for your amazing contributions to this the Childhood Arthritis and Beyond Conference! Has been humbling to reflect on an incredible few days, renewing acquaintances and making new connections, sharing discoveries, listening to the brave voices of our patients and families, and building bridges toward a cure for childhood arthritis. From our chairs, speakers and panelists to our highly-engaged attendees, you made this a special gathering of our community. Our heartfelt thanks to you for bringing your knowledge, experiences, and passion to the event.

Sincerely,
Rae, Susa, Bas, Joost and Deborah
Co-chairs of the CABC 2024 Organizing Committee

acheng2024-06-03T16:09:59+00:00

Canadian Rheumatology Association – Best Abstract by a Post-Graduate Research Trainee

Health Economics Team Highlight: Luiza Grazziotin

Luiza has worked incredibly hard with the UCAN Health Economics team and presented her work on medication costs in JIA at the 2021 Canadian Rheumatology Association conference. Luiza and the team’s work was recognized as Luiza won the award for Best Abstract by a Post-Graduate Research Trainee on her project entitled ‘Disentangling the Web of Costs Associated with Juvenile Idiopathic Arthritis’.

Here is Luiza’s abstract from the CRA website. Congratulations Luiza!

Frank Silverio2021-09-25T20:58:00+00:00

Arthritis Society – Top 10 Research Advances of 2019

We are very proud to announce that members of our team are being recognized for their contributions to the scientific community.

In November, the work of UCAN bioinformatician Dr Simon Eng, under the supervision of Dr Rae Yeung and Dr Quaid Morris, was selected as one of the Arthritis Society’s Top 10 Research Advances of 2019!

Here’s the article from the Arthritis Society website.

Frank Silverio2021-09-25T20:58:24+00:00

Rare Disease and Genomics in 3D: From Diagnostics to Drug Discovery

Dr. Rae Yeung will join a panel of leaders from Canada’s genomics sector at the 2019 BIO International convention in Philadelphia, USA on June 3, 2019.

For more information, visit the Genome Canada announcement.

Simon Eng2019-05-31T19:06:00+00:00